Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

LifeVantage expands board with new director appointment

Published 15/02/2024, 21:48
Updated 15/02/2024, 21:48
© Reuters.

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Dayton Judd to its Board of Directors, effective immediately. This addition is part of a Cooperation Agreement with the Radoff-Sudbury Group, which owns approximately 12.6% of LifeVantage's outstanding stock. The agreement follows ongoing discussions since the annual meeting of shareholders on November 6, 2023.

Dayton Judd brings a wealth of experience to the board, including his current role as CEO of FitLife Brands, Inc. (NASDAQ: FTLF), and his background in investment advisory and management consulting. Judd's financial and industry expertise is anticipated to contribute significantly to LifeVantage's growth and profitability, according to Ray Greer, Chairman of the Board.

Steve Fife, President and CEO of LifeVantage, expressed confidence in the company's LV360 initiatives to drive profitability and the intention to return Adjusted EBITDA margins to double-digit levels. The company also plans to continue delivering value to shareholders through dividends and share repurchases, supported by a robust balance sheet.

The Radoff-Sudbury Group has committed to customary standstill and voting provisions under the Cooperation Agreement. Further details of the agreement will be disclosed in a Form 8-K filing with the U.S. Securities and Exchange Commission.

LifeVantage, headquartered in Lehi, Utah, is known for its range of dietary supplements and wellness products aimed at supporting health at a genetic level. The company's flagship products include the Protandim® family, as well as a variety of other health and wellness offerings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.